Influence of baseline characteristics on subjective improvement of dry eye after intense pulsed light therapy
To identify baseline clinical signs and symptoms associated with response to intense pulsed light (IPL) combined with meibomian gland expression in dry eye disease (DED), and to develop machine learning (ML) models for individualized outcome prediction. This retrospective study analyzed 100 eyes fro...
Uloženo v:
| Vydáno v: | Contact lens & anterior eye s. 102514 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
07.10.2025
|
| Témata: | |
| ISSN: | 1367-0484, 1476-5411, 1476-5411 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | To identify baseline clinical signs and symptoms associated with response to intense pulsed light (IPL) combined with meibomian gland expression in dry eye disease (DED), and to develop machine learning (ML) models for individualized outcome prediction.
This retrospective study analyzed 100 eyes from 100 DED patients (aged 58.6 ± 13.4 years) treated with IPL and meibomian gland expression. Baseline parameters assessed with the Antares system included meibomian gland loss (MGL), tear meniscus height (TMH), non-invasive tear break-up time (NIBUT), conjunctival hyperemia, and Ocular Surface Disease Index (OSDI). Patients were stratified by change in OSDI after treatment (ΔOSDI): Class 1 (no improvement), Class 2 (mild improvement), and Class 3 (clear improvement). Several ML models were trained to predict ΔOSDI from baseline parameters.
IPL significantly improved both symptoms and signs. OSDI decreased from 44.65 ± 18.3 to 28.47 ± 19.3 (p < 0.001), NIBUT increased from 4.5 ± 3.2 to 7.5 ± 6.5 s (p < 0.001), and TMH and conjunctival hyperemia also improved (p < 0.001), while MGL and BCVA remained stable. Greater improvement was observed in patients with higher baseline OSDI (p = 0.001). The XGBoost algorithm achieved the highest predictive performance (AUC-ROC = 0.77), with OSDI and NIBUT as the strongest predictors based on SHAP analysis.
IPL combined with meibomian gland expression improves symptoms and signs in DED, particularly in patients with more severe baseline symptoms. Baseline OSDI and NIBUT were the strongest predictors of response. ML models demonstrated moderate accuracy, supporting their potential role in personalized DED treatment strategies. |
|---|---|
| AbstractList | To identify baseline clinical signs and symptoms associated with response to intense pulsed light (IPL) combined with meibomian gland expression in dry eye disease (DED), and to develop machine learning (ML) models for individualized outcome prediction.PURPOSETo identify baseline clinical signs and symptoms associated with response to intense pulsed light (IPL) combined with meibomian gland expression in dry eye disease (DED), and to develop machine learning (ML) models for individualized outcome prediction.This retrospective study analyzed 100 eyes from 100 DED patients (aged 58.6 ± 13.4 years) treated with IPL and meibomian gland expression. Baseline parameters assessed with the Antares system included meibomian gland loss (MGL), tear meniscus height (TMH), non-invasive tear break-up time (NIBUT), conjunctival hyperemia, and Ocular Surface Disease Index (OSDI). Patients were stratified by change in OSDI after treatment (ΔOSDI): Class 1 (no improvement), Class 2 (mild improvement), and Class 3 (clear improvement). Several ML models were trained to predict ΔOSDI from baseline parameters.METHODSThis retrospective study analyzed 100 eyes from 100 DED patients (aged 58.6 ± 13.4 years) treated with IPL and meibomian gland expression. Baseline parameters assessed with the Antares system included meibomian gland loss (MGL), tear meniscus height (TMH), non-invasive tear break-up time (NIBUT), conjunctival hyperemia, and Ocular Surface Disease Index (OSDI). Patients were stratified by change in OSDI after treatment (ΔOSDI): Class 1 (no improvement), Class 2 (mild improvement), and Class 3 (clear improvement). Several ML models were trained to predict ΔOSDI from baseline parameters.IPL significantly improved both symptoms and signs. OSDI decreased from 44.65 ± 18.3 to 28.47 ± 19.3 (p < 0.001), NIBUT increased from 4.5 ± 3.2 to 7.5 ± 6.5 s (p < 0.001), and TMH and conjunctival hyperemia also improved (p < 0.001), while MGL and BCVA remained stable. Greater improvement was observed in patients with higher baseline OSDI (p = 0.001). The XGBoost algorithm achieved the highest predictive performance (AUC-ROC = 0.77), with OSDI and NIBUT as the strongest predictors based on SHAP analysis.RESULTSIPL significantly improved both symptoms and signs. OSDI decreased from 44.65 ± 18.3 to 28.47 ± 19.3 (p < 0.001), NIBUT increased from 4.5 ± 3.2 to 7.5 ± 6.5 s (p < 0.001), and TMH and conjunctival hyperemia also improved (p < 0.001), while MGL and BCVA remained stable. Greater improvement was observed in patients with higher baseline OSDI (p = 0.001). The XGBoost algorithm achieved the highest predictive performance (AUC-ROC = 0.77), with OSDI and NIBUT as the strongest predictors based on SHAP analysis.IPL combined with meibomian gland expression improves symptoms and signs in DED, particularly in patients with more severe baseline symptoms. Baseline OSDI and NIBUT were the strongest predictors of response. ML models demonstrated moderate accuracy, supporting their potential role in personalized DED treatment strategies.CONCLUSIONSIPL combined with meibomian gland expression improves symptoms and signs in DED, particularly in patients with more severe baseline symptoms. Baseline OSDI and NIBUT were the strongest predictors of response. ML models demonstrated moderate accuracy, supporting their potential role in personalized DED treatment strategies. To identify baseline clinical signs and symptoms associated with response to intense pulsed light (IPL) combined with meibomian gland expression in dry eye disease (DED), and to develop machine learning (ML) models for individualized outcome prediction. This retrospective study analyzed 100 eyes from 100 DED patients (aged 58.6 ± 13.4 years) treated with IPL and meibomian gland expression. Baseline parameters assessed with the Antares system included meibomian gland loss (MGL), tear meniscus height (TMH), non-invasive tear break-up time (NIBUT), conjunctival hyperemia, and Ocular Surface Disease Index (OSDI). Patients were stratified by change in OSDI after treatment (ΔOSDI): Class 1 (no improvement), Class 2 (mild improvement), and Class 3 (clear improvement). Several ML models were trained to predict ΔOSDI from baseline parameters. IPL significantly improved both symptoms and signs. OSDI decreased from 44.65 ± 18.3 to 28.47 ± 19.3 (p < 0.001), NIBUT increased from 4.5 ± 3.2 to 7.5 ± 6.5 s (p < 0.001), and TMH and conjunctival hyperemia also improved (p < 0.001), while MGL and BCVA remained stable. Greater improvement was observed in patients with higher baseline OSDI (p = 0.001). The XGBoost algorithm achieved the highest predictive performance (AUC-ROC = 0.77), with OSDI and NIBUT as the strongest predictors based on SHAP analysis. IPL combined with meibomian gland expression improves symptoms and signs in DED, particularly in patients with more severe baseline symptoms. Baseline OSDI and NIBUT were the strongest predictors of response. ML models demonstrated moderate accuracy, supporting their potential role in personalized DED treatment strategies. |
| ArticleNumber | 102514 |
| Author | Cano-Ortiz, Antonio López Pérez, María Dolores Ortiz-Peregrina, Sonia González-Cruces, Timoteo Carrillo-Pulido, Miriam |
| Author_xml | – sequence: 1 givenname: Miriam orcidid: 0009-0004-8439-2749 surname: Carrillo-Pulido fullname: Carrillo-Pulido, Miriam – sequence: 2 givenname: Sonia surname: Ortiz-Peregrina fullname: Ortiz-Peregrina, Sonia – sequence: 3 givenname: María Dolores surname: López Pérez fullname: López Pérez, María Dolores – sequence: 4 givenname: Antonio surname: Cano-Ortiz fullname: Cano-Ortiz, Antonio – sequence: 5 givenname: Timoteo surname: González-Cruces fullname: González-Cruces, Timoteo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/41062344$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kctuwyAQRVGVqnm0P9BFxbIbp4CxiZdV1EekSN20a0RgaLBsnIIdKX9frKRdMbo6d4TmzNHEdx4QuqdkSQktn-qlbhQsGWFFClhB-RWaUS7KrOCUTtKclyIjfMWnaB5jTVKpqsgNmnJKSpZzPkPtxttmAK8BdxbvVITGecB6r4LSPQQXe6cj7jyOw64G3bsjYNceQneEFnw_tkw4YTgBVjYVsPM9-Aj4MDQRDG7c977H_R6COpxu0bVVKb67vAv09fryuX7Pth9vm_XzNtOMFjwriTY6Z1xwqIhlprCMG0JKwQ0rbVVpI7gAanbEaqGNXaVQkKKiQGnOlMkX6PG8N_3zZ4DYy9ZFDU2jPHRDlDkrKiIEqYqEPlzQYdeCkYfgWhVO8u9ECWBnQIcuxgD2H6FEjh5kLUcPcvQgzx7yXzjPfSQ |
| Cites_doi | 10.1167/iovs.14-15764 10.1016/j.jtos.2017.05.001 10.1016/j.jtos.2017.05.008 10.1167/iovs.10-6997b 10.2147/OPTH.S318885 10.25289/ML.2019.8.2.50 10.3390/jcm10163573 10.1177/11206721231199121 10.1097/ICL.0000000000000307 10.2147/OPTH.S321764 10.1097/ICL.0000000000000711 10.1111/opo.13302 10.1016/j.jcjo.2016.01.005 10.1016/j.jtos.2025.02.008 10.1007/s10792-020-01292-w 10.1016/j.jtos.2025.02.005 10.1016/j.ajo.2025.05.033 10.1080/08820538.2020.1755321 10.1016/j.jtos.2017.05.011 10.1080/08820538.2018.1551496 10.21037/apm-21-1303 10.1097/ICL.0000000000000958 10.1016/j.jtos.2023.01.005 10.1016/j.jtos.2017.05.003 10.3390/medicina57060619 10.1016/j.heliyon.2024.e36021 10.1111/opo.13373 10.1016/j.jtos.2017.05.006 10.3390/diagnostics12123167 10.1167/iovs.10-6997e |
| ContentType | Journal Article |
| Copyright | Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.clae.2025.102514 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1476-5411 |
| ExternalDocumentID | 41062344 10_1016_j_clae_2025_102514 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29F 4.4 457 4G. 53G 5GY 5VS 6PF 7-5 71M 8P~ 9DU AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO AAYXX ABBQC ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACJTP ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXBA AFXIZ AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CITATION COF CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OF- OPF OQ~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SEL SES SEW SNG SPCBC SSH SSZ T5K Z5R ~G- ~HD NPM 7X8 |
| ID | FETCH-LOGICAL-c2154-60cdc32474e90f2d5f24d00674d26f99cd747e1db0fc7cdf86f970591e1132ad3 |
| ISSN | 1367-0484 1476-5411 |
| IngestDate | Thu Oct 09 19:01:06 EDT 2025 Fri Oct 10 01:50:40 EDT 2025 Sat Nov 29 06:49:50 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Intense pulsed light therapy Dry eye disease Meibomian gland dysfunction Predictive algorithms Machine learning |
| Language | English |
| License | Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c2154-60cdc32474e90f2d5f24d00674d26f99cd747e1db0fc7cdf86f970591e1132ad3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0009-0004-8439-2749 |
| OpenAccessLink | https://www.contactlensjournal.com/article/S1367-0484(25)00148-1/pdf |
| PMID | 41062344 |
| PQID | 3259077095 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3259077095 pubmed_primary_41062344 crossref_primary_10_1016_j_clae_2025_102514 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-Oct-07 |
| PublicationDateYYYYMMDD | 2025-10-07 |
| PublicationDate_xml | – month: 10 year: 2025 text: 2025-Oct-07 day: 07 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Contact lens & anterior eye |
| PublicationTitleAlternate | Cont Lens Anterior Eye |
| PublicationYear | 2025 |
| References | Garaszczuk (10.1016/j.clae.2025.102514_b0120) 2024; 44 Jones (10.1016/j.clae.2025.102514_b0035) 2017; 15 Bron (10.1016/j.clae.2025.102514_b0025) 2017; 15 Gupta (10.1016/j.clae.2025.102514_b0080) 2016; 51 Garza-Leon (10.1016/j.clae.2025.102514_b0100) 2020; 40 Stapleton (10.1016/j.clae.2025.102514_b0005) 2017; 15 Wolffsohn (10.1016/j.clae.2025.102514_b0010) 2025 Goo (10.1016/j.clae.2025.102514_b0130) 2019; 8 Gala-Núñez (10.1016/j.clae.2025.102514_b0075) 2024; 44 Ballesteros-Sánchez (10.1016/j.clae.2025.102514_b0085) 2023; 49 Schaumberg (10.1016/j.clae.2025.102514_b0140) 2011; 52 Yan (10.1016/j.clae.2025.102514_b0065) 2021; 10 Abdelmotaal (10.1016/j.clae.2025.102514_b0175) 2023; 28 Garza-Leon (10.1016/j.clae.2025.102514_b0105) 2017; 91 Sanal Dogan (10.1016/j.clae.2025.102514_b0110) 2018; 44 Craig (10.1016/j.clae.2025.102514_b0125) 2015; 56 Solomos (10.1016/j.clae.2025.102514_b0145) 2021; 57 Craig (10.1016/j.clae.2025.102514_b0015) 2017; 15 Nair (10.1016/j.clae.2025.102514_b0165) 2024; 16 Iradier (10.1016/j.clae.2025.102514_b0060) 2021; 10 Yan (10.1016/j.clae.2025.102514_b0070) 2021; 47 Consejo (10.1016/j.clae.2025.102514_b0115) 2019; 34 Lee (10.1016/j.clae.2025.102514_b0170) 2020; 35 Nelson (10.1016/j.clae.2025.102514_b0040) 2011; 52 Sánchez-González (10.1016/j.clae.2025.102514_b0090) 2022; 10 Riley (10.1016/j.clae.2025.102514_b0095) 2020; 18 Ballesteros-Sánchez (10.1016/j.clae.2025.102514_b0055) 2025; 37 Chase (10.1016/j.clae.2025.102514_b0155) 2021; 15 Park (10.1016/j.clae.2025.102514_b0135) 2022; 12 Marta (10.1016/j.clae.2025.102514_b0050) 2021; 15 Kandel (10.1016/j.clae.2025.102514_b0030) 2025; 37 Benitez-Del-Castillo (10.1016/j.clae.2025.102514_b0045) 2024; 34 Graham (10.1016/j.clae.2025.102514_b0150) 2024; 10 Wolffsohn (10.1016/j.clae.2025.102514_b0020) 2017; 15 Yang (10.1016/j.clae.2025.102514_b0160) 2022; 12 |
| References_xml | – volume: 56 start-page: 1965 issue: 3 year: 2015 ident: 10.1016/j.clae.2025.102514_b0125 article-title: Prospective trial of intense pulsed light for the treatment of Meibomian gland dysfunction publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.14-15764 – volume: 15 start-page: 539 year: 2017 ident: 10.1016/j.clae.2025.102514_b0020 article-title: TFOS DEWS II diagnostic methodology report publication-title: Ocul Surf doi: 10.1016/j.jtos.2017.05.001 – volume: 15 start-page: 276 year: 2017 ident: 10.1016/j.clae.2025.102514_b0015 article-title: TFOS DEWS II definition and classification report publication-title: Ocul Surf doi: 10.1016/j.jtos.2017.05.008 – volume: 52 start-page: 1930 year: 2011 ident: 10.1016/j.clae.2025.102514_b0040 article-title: The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.10-6997b – volume: 15 start-page: 2803 year: 2021 ident: 10.1016/j.clae.2025.102514_b0050 article-title: Intense pulsed plus low-level light therapy in meibomian gland dysfunction publication-title: Clin Ophthalmol doi: 10.2147/OPTH.S318885 – volume: 10 issue: 9 year: 2022 ident: 10.1016/j.clae.2025.102514_b0090 article-title: Dry eye disease and tear film assessment through a novel non-invasive ocular surface analyzer: the OSA protocol publication-title: Front Med (Lausanne) – volume: 8 start-page: 50 issue: 2 year: 2019 ident: 10.1016/j.clae.2025.102514_b0130 article-title: Effects of low-level light therapy at 740 nm on dry eye disease in vivo publication-title: Med Lasers doi: 10.25289/ML.2019.8.2.50 – volume: 10 start-page: 3573 year: 2021 ident: 10.1016/j.clae.2025.102514_b0060 article-title: Characterization and prediction of the clinical outcome of intense pulsed light-based treatment in dry eye associated to Meibomian gland dysfunction publication-title: J Clin Med doi: 10.3390/jcm10163573 – volume: 34 start-page: 700 year: 2024 ident: 10.1016/j.clae.2025.102514_b0045 article-title: Efficacy and safety of intense pulsed light of upper and lower eyelids in Meibomian gland dysfunction: a prospective multicentric study publication-title: Eur J Ophthalmol doi: 10.1177/11206721231199121 – volume: 44 start-page: 113 issue: 2 year: 2018 ident: 10.1016/j.clae.2025.102514_b0110 article-title: Interexaminer reliability of meibography: upper or lower eyelid? publication-title: Eye Contact Lens doi: 10.1097/ICL.0000000000000307 – volume: 15 start-page: 4281 year: 2021 ident: 10.1016/j.clae.2025.102514_b0155 article-title: Comparison of autonomous AS-OCT deep learning algorithm and clinical dry eye tests in diagnosis of dry eye disease publication-title: Clin Ophthalmol doi: 10.2147/OPTH.S321764 – volume: 47 start-page: 45 issue: 1 year: 2021 ident: 10.1016/j.clae.2025.102514_b0070 article-title: The efficacy of intense pulsed light combined with Meibomian gland expression for the treatment of dry eye disease due to Meibomian gland dysfunction: a multicenter, randomized controlled trial publication-title: Eye Contact Lens doi: 10.1097/ICL.0000000000000711 – volume: 44 start-page: 727 issue: 4 year: 2024 ident: 10.1016/j.clae.2025.102514_b0120 article-title: Machine learning-based prediction of tear osmolarity for contact lens practice publication-title: Ophthalmic Physiol Opt doi: 10.1111/opo.13302 – volume: 18 issue: 368 year: 2020 ident: 10.1016/j.clae.2025.102514_b0095 article-title: Calculating the sample size required for developing a clinical prediction model publication-title: BMJ – volume: 51 start-page: 249 issue: 4 year: 2016 ident: 10.1016/j.clae.2025.102514_b0080 article-title: Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease publication-title: Can J Ophthalmol doi: 10.1016/j.jcjo.2016.01.005 – volume: 37 start-page: 33 year: 2025 ident: 10.1016/j.clae.2025.102514_b0055 article-title: Efficacy of eyelid warming devices as first-step treatment in Meibomian gland dysfunction: a systematic review with meta-analysis publication-title: Ocul Surf doi: 10.1016/j.jtos.2025.02.008 – volume: 40 start-page: 1261 issue: 5 year: 2020 ident: 10.1016/j.clae.2025.102514_b0100 article-title: Comparison of Meibomian gland loss area measurements between two computer programs and intra-inter-observer agreement publication-title: Int Ophthalmol doi: 10.1007/s10792-020-01292-w – volume: 37 start-page: 11 year: 2025 ident: 10.1016/j.clae.2025.102514_b0030 article-title: The impact of dry eye disease on patient-reported quality of life: a save sight dry eye registry study publication-title: Ocul Surf doi: 10.1016/j.jtos.2025.02.005 – year: 2025 ident: 10.1016/j.clae.2025.102514_b0010 article-title: TFOS DEWS III diagnostic methodology publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2025.05.033 – volume: 12 issue: 1 year: 2022 ident: 10.1016/j.clae.2025.102514_b0135 article-title: Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial publication-title: Sci Rep – volume: 35 start-page: 134 issue: 2 year: 2020 ident: 10.1016/j.clae.2025.102514_b0170 article-title: Clinical accuracy of an advanced corneal topographer with tear-film analysis in functional and structural evaluation of dry eye disease publication-title: Semin Ophthalmol doi: 10.1080/08820538.2020.1755321 – volume: 15 start-page: 438 year: 2017 ident: 10.1016/j.clae.2025.102514_b0025 article-title: TFOS DEWS II pathophysiology report publication-title: Ocul Surf doi: 10.1016/j.jtos.2017.05.011 – volume: 34 start-page: 19 issue: 1 year: 2019 ident: 10.1016/j.clae.2025.102514_b0115 article-title: Introduction to machine learning for ophthalmologists publication-title: Semin Ophthalmol doi: 10.1080/08820538.2018.1551496 – volume: 10 issue: 7 year: 2021 ident: 10.1016/j.clae.2025.102514_b0065 article-title: Efficacy and safety of intense pulsed light therapy for dry eye caused by Meibomian gland dysfunction: a randomised trial publication-title: Ann Palliat Med doi: 10.21037/apm-21-1303 – volume: 49 start-page: 8 issue: 1 year: 2023 ident: 10.1016/j.clae.2025.102514_b0085 article-title: Intense pulse light combined with low-level light therapy in dry eye disease: a systematic review publication-title: Eye Contact Lens doi: 10.1097/ICL.0000000000000958 – volume: 28 start-page: 90 year: 2023 ident: 10.1016/j.clae.2025.102514_b0175 article-title: Detecting dry eye from ocular surface videos based on deep learning publication-title: Ocul Surf doi: 10.1016/j.jtos.2023.01.005 – volume: 16 issue: 9 year: 2024 ident: 10.1016/j.clae.2025.102514_b0165 article-title: Artificial intelligence in dry eye disease: a narrative review publication-title: Cureus – volume: 15 start-page: 334 year: 2017 ident: 10.1016/j.clae.2025.102514_b0005 article-title: TFOS DEWS II epidemiology report publication-title: Ocul Surf doi: 10.1016/j.jtos.2017.05.003 – volume: 57 start-page: 619 issue: 6 year: 2021 ident: 10.1016/j.clae.2025.102514_b0145 article-title: Meibomian gland dysfunction: intense pulsed light therapy in combination with low-level light therapy as rescue treatment publication-title: Medicina (Kaunas) doi: 10.3390/medicina57060619 – volume: 10 issue: 17 year: 2024 ident: 10.1016/j.clae.2025.102514_b0150 article-title: A machine learning approach to predicting dry eye-related signs, symptoms and diagnoses from meibography images publication-title: Heliyon doi: 10.1016/j.heliyon.2024.e36021 – volume: 44 start-page: 1472 issue: 7 year: 2024 ident: 10.1016/j.clae.2025.102514_b0075 article-title: Development of a dry eye index as a new biomarker of dry eye disease publication-title: Ophthalmic Physiol Opt doi: 10.1111/opo.13373 – volume: 15 start-page: 575 year: 2017 ident: 10.1016/j.clae.2025.102514_b0035 article-title: TFOS DEWS II management and therapy report publication-title: Ocul Surf doi: 10.1016/j.jtos.2017.05.006 – volume: 91 start-page: 165 issue: 4 year: 2017 ident: 10.1016/j.clae.2025.102514_b0105 article-title: A new technology for the evaluation of Meibomian glands publication-title: Rev Mex Oftalmol – volume: 12 start-page: 3167 issue: 12 year: 2022 ident: 10.1016/j.clae.2025.102514_b0160 article-title: Integration of artificial intelligence into the approach for diagnosis and monitoring of dry eye disease publication-title: Diagnostics doi: 10.3390/diagnostics12123167 – volume: 52 start-page: 1994 issue: 4 year: 2011 ident: 10.1016/j.clae.2025.102514_b0140 article-title: The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for publication-title: MGD Invest Ophthalmol Vis Sci doi: 10.1167/iovs.10-6997e |
| SSID | ssj0016990 |
| Score | 2.3844006 |
| SecondaryResourceType | online_first |
| Snippet | To identify baseline clinical signs and symptoms associated with response to intense pulsed light (IPL) combined with meibomian gland expression in dry eye... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database |
| StartPage | 102514 |
| Title | Influence of baseline characteristics on subjective improvement of dry eye after intense pulsed light therapy |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/41062344 https://www.proquest.com/docview/3259077095 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1476-5411 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016990 issn: 1367-0484 databaseCode: AIEXJ dateStart: 20210601 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9tAEF4cp4RcSt91H2ELvQkZ67nSMXVTmpIEQ9Pim5D2EWRkrZCtkOQn9Vd2dleSXbeB9tCLMJK9wjMfM9_sPBah9xOHx9xnru0xoG_gIVI7zkJmq55KGlMRcH1-yvczcnERzefxbDD40fXCXBekLKObm7j6r6qGe6Bs1Tr7D-ruF4Ub8BmUDldQO1z_SvGn3bEjigcqJ6WJJN0ZzAxKXzXZwpg71StZSz05XBcGMNWhe8vbA8RzXeXOraoBN8qsQoXz1nprGkE36ECWa9VxCX5spRGllZarkeK3PXymaV3nRSHtWVPkTJrKfZDKst_thX90Z894za_q3DSsfQW703uPM5Xa_-BV_M6amSx_bTbBz1OT9f-YQlRQyHpTHDlNS2nrddtxCbCe3N7ucPWYVHMu7pgbE-2T0A781kQbs-uoSMn_o0cwmxOLMS1SNRXVDca_fxkUWC01HHyIkF3PTKTcmcPdPdpD-y4J4miI9o9PT-Zf-pxVCI69bcsyFYS7rzxEB90iv7Kge0IbTXEuH6GHbWyCjw2mHqMBL5-gg_O2-uIpWvbQwlLgDlp4B1pYlngDLbwFLfUrgBYGOGANLdxCCxtoYQ0t3ELrGfr26eRy-tluj-uwKfBG3w4nlFHg58Tn8US4LBCuzxQbAlMQijimDEJX7rBsIiihTERwkwC7d7jjeG7KvOdoWMqSv0RYBDRlwJyjLFWJ-xhoahSCuckcAQ5JeCNkdeJLKjOVJenKFReJknui5J4YuY_Qu07CCRhPlRFLSy6bVeJB8D8hBMKMEXphRN-v16nq1b1PXqPDDULfoOG6bvhb9IBer_NVfYT2yDw6akHyEw8_lvo |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+baseline+characteristics+on+subjective+improvement+of+dry+eye+after+intense+pulsed+light+therapy&rft.jtitle=Contact+lens+%26+anterior+eye&rft.au=Carrillo-Pulido%2C+Miriam&rft.au=Ortiz-Peregrina%2C+Sonia&rft.au=L%C3%B3pez+P%C3%A9rez%2C+Mar%C3%ADa+Dolores&rft.au=Cano-Ortiz%2C+Antonio&rft.date=2025-10-07&rft.eissn=1476-5411&rft.spage=102514&rft_id=info:doi/10.1016%2Fj.clae.2025.102514&rft_id=info%3Apmid%2F41062344&rft.externalDocID=41062344 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1367-0484&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1367-0484&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1367-0484&client=summon |